Janssen TECVAYLI gets USFDA nod for relapsed or refractory multiple myeloma

Press/Media

Period	29 Oct 2022

Media coverage

Title	Janssen TECVAYLI gets USFDA nod for relapsed or refractory multiple myeloma
Media name/outlet	Medical Dialogues
Country/Territory	India
Date	29/10/22
URL	https://medicaldialogues.in/news/industry/pharma/janssen-tecvayli-gets-usfda-nod-for-relapsed-or-refractory-multiple-myeloma-101367
Persons	Ajai Chari